市場調査レポート

商品コード

1451475

粘膜噴霧デバイス市場レポート：製品タイプ、技術、エンドユーザー、地域別、2024-2032

Mucosal Atomization Devices Market Report by Product Type, Technology, End User, and Region 2024-2032

出版日: 2024年03月02日 | 発行: IMARC

| ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 3,899 607,698円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 4,899 763,558円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 5,899 919,418円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.86円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の粘膜噴霧デバイス市場規模は2023年に7億7,210万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに13億70万米ドルに達し、2024-2032年の成長率（CAGR）は5.92%になると予測しています。世界市場は、技術の進歩、緊急医療における効率的なドラッグデリバリーに対する需要の増加、ヘルスケアにおける用途の拡大、アジア太平洋を中心とした新興国における医療インフラの急速な拡大などを背景に急成長しています。

粘膜噴霧デバイス市場の分析：

市場の成長と規模：粘膜噴霧デバイス市場は、様々な医療分野での需要増加に起因して、著しい成長を遂げています。市場の拡大は、救急医療と外来医療の両方で効率的な薬物送達システムに対するニーズが高まっていることがさらなる原動力となっています。

主な市場促進要因：主な促進要因としては、粘膜微粒化によるドラッグデリバリーの効率化、慢性疾患の蔓延、迅速な投薬の必要性などが挙げられます。技術の進歩やヘルスケア専門家の意識の高まりも、市場成長の推進に重要な役割を果たしています。

技術の進歩：微粒化の品質、使いやすさ、携帯性の向上を目指した開発により、機器の設計と機能性における絶え間ない革新がこの市場を特徴付けています。投与量の管理と患者のコンプライアンスを向上させるためのデジタルヘルス技術の統合は、新たな動向です。

産業用途：粘膜微粒化装置は、救急医療、疼痛管理、耳鼻咽喉科処置、慢性疾患治療などに幅広く応用されています。非侵襲的な性質と迅速な薬物吸収能力により、多様な医療シナリオに適しています。

主な市場動向：市場は、より小型で効率的、かつ費用対効果の高い機器を求める傾向にあります。また、患者の快適性とコンプライアンスへの注目も高まっており、使いやすい噴霧装置の開発を後押ししています。

地理的動向：北米は高度なヘルスケア・インフラを有し、慢性疾患の有病率が高いため、市場を独占しています。アジア太平洋と欧州も重要な市場であり、ヘルスケア施設の拡大と医療支出の増加により急成長を示しています。

競合情勢：同市場は、戦略的提携、研究開発投資、新市場への進出に取り組む主要企業の存在によって特徴付けられています。これらの企業は、製品ポートフォリオを強化し、世界市場でのポジションを強化することに注力しています。

課題と機会：課題には、厳しい規制基準や継続的な技術進歩の必要性などがあります。しかし、こうした課題は、特に発展途上地域や新興国市場において、変化するヘルスケアニーズに対応する新製品の革新と開発の機会をもたらします。

粘膜噴霧デバイスの市場動向：

ドラッグデリバリー効率の向上

粘膜微粒化装置は、特に救急医療や外来診療の現場でドラッグデリバリーの効率を高めることができるため、脚光を浴びています。これらのデバイスは、粘膜からの薬物の迅速な吸収を促進し、従来の送達方法と比較して迅速な作用発現につながります。これは、疼痛管理、発作抑制、オピオイド過剰摂取の回復など、即時の医療介入が必要な場合に特に重要です。噴霧化によって生じる微細な霧は、薬物吸収のための表面積を大きくし、バイオアベイラビリティを向上させる。この方法はまた、消化管を迂回するため、初回通過代謝や胃腸障害といった経口投与に関連する懸念がないです。さらに、粘膜微粒化は非侵襲的であるため、患者、特に小児や錠剤を飲み込むことが困難な患者にも受け入れられやすいです。患者の快適性が重視されるようになり、さまざまな臨床場面で迅速かつ効果的な薬物投与の必要性が高まっていることが、これらの機器の市場を大きく牽引しています。

技術の進歩と製品の革新

同市場は、継続的な技術の進歩と製品の革新によって支えられています。最新のデバイスは霧化の質を改善し、粘膜吸収を高める一貫した粒子径を実現しています。設計の革新により、より使いやすく、携帯可能で、使い捨て可能な噴霧器が開発され、多様な医療現場での使用が拡大しています。材料と製造技術の開発により、これらの装置のコストも下がり、より利用しやすくなっています。特定の医療要件に対応し、投与量や噴霧パターンをより適切に制御できる装置の開発に注目が集まっています。さらに、電子カルテとの統合による投与量の追跡や患者のコンプライアンスなど、デジタルヘルス技術の進歩も新たな動向となっています。これらの機器の有効性、安全性、利便性の向上を目指した研究開発の進行は、この市場の拡大に大きく寄与しています。

さまざまな医療用途での需要の高まり

これらの機器の応用範囲は多くの医療分野に広がっており、市場の成長を後押ししています。救急医療では、これらの機器は重篤な状況での迅速な薬剤投与に不可欠です。耳鼻咽喉科では、処置中の効率的な局所麻酔に使用されます。疼痛管理、特に経口薬の服用が困難な患者への使用は、もう一つの重要な応用分野です。糖尿病やホルモン障害など、定期的な投薬が必要な慢性疾患の有病率の増加は、ドラッグデリバリーのための粘膜微粒化使用のさらなる機会を提示しています。さらに、COVID-19の大流行により、効果的で安全なドラッグデリバリー方法の必要性が浮き彫りになり、粘膜微粒化がワクチン投与用に検討されています。様々な医療分野でのこれらの装置の汎用性と用途の拡大は、粘膜噴霧デバイス市場の需要増加と拡大に大きく貢献しています。

北米
- 米国
  - 市場動向
  - 市場予測
- カナダ
  - 市場動向
  - 市場予測
アジア太平洋
- 中国
  - 市場動向
  - 市場予測
- 日本
  - 市場動向
  - 市場予測
- インド
  - 市場動向
  - 市場予測
- 韓国
  - 市場動向
  - 市場予測
- オーストラリア
  - 市場動向
  - 市場予測
- インドネシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
欧州
- ドイツ
  - 市場動向
  - 市場予測
- フランス
  - 市場動向
  - 市場予測
- 英国
  - 市場動向
  - 市場予測
- イタリア
  - 市場動向
  - 市場予測
- スペイン
  - 市場動向
  - 市場予測
- ロシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
ラテンアメリカ
- ブラジル
  - 市場動向
  - 市場予測
- メキシコ
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
中東・アフリカ地域
- 市場動向
- 市場内訳：国別
- 市場予測

第10章 SWOT分析

概要
強み
弱み
機会
脅威

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第13章価格分析

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Becton Dickinson and Company
- DeVilbiss Healthcare LLC（Drive DeVilbiss Healthcare）
- Kurve Technology Inc.
- Life-Assist Inc.
- Medica Holdings LLC
- MedTree（BTME Group Ltd.）
- Teleflex Incorporated

図表

List of Figures

Figure 1: Global: Mucosal Atomization Devices Market: Major Drivers and Challenges
Figure 2: Global: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Mucosal Atomization Devices Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Mucosal Atomization Devices Market: Breakup by Technology (in %), 2023
Figure 6: Global: Mucosal Atomization Devices Market: Breakup by End User (in %), 2023
Figure 7: Global: Mucosal Atomization Devices Market: Breakup by Region (in %), 2023
Figure 8: Global: Mucosal Atomization Devices (Nasal Atomization Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Mucosal Atomization Devices (Nasal Atomization Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Mucosal Atomization Devices (Fiber-Optic Atomization Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Mucosal Atomization Devices (Fiber-Optic Atomization Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Mucosal Atomization Devices (Laryngo-Tracheal Atomization Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Mucosal Atomization Devices (Laryngo-Tracheal Atomization Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Mucosal Atomization Devices (Bottle Atomizer Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Mucosal Atomization Devices (Bottle Atomizer Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Mucosal Atomization Devices (Gas Propelled) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Mucosal Atomization Devices (Gas Propelled) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Mucosal Atomization Devices (Electrical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Mucosal Atomization Devices (Electrical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Mucosal Atomization Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Mucosal Atomization Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Mucosal Atomization Devices (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Mucosal Atomization Devices (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Mucosal Atomization Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Mucosal Atomization Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Mucosal Atomization Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Mucosal Atomization Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: North America: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: North America: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: United States: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: United States: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Canada: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Canada: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Asia-Pacific: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Asia-Pacific: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: China: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: China: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Japan: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Japan: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: India: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: India: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: South Korea: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: South Korea: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Australia: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Australia: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Indonesia: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Indonesia: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Others: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Others: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Germany: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Germany: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: France: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: France: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: United Kingdom: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: United Kingdom: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Italy: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Spain: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Spain: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Russia: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Russia: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Latin America: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Latin America: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Brazil: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Brazil: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Mexico: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Mexico: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Middle East and Africa: Mucosal Atomization Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Middle East and Africa: Mucosal Atomization Devices Market: Breakup by Country (in %), 2023
Figure 76: Middle East and Africa: Mucosal Atomization Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Mucosal Atomization Devices Industry: SWOT Analysis
Figure 78: Global: Mucosal Atomization Devices Industry: Value Chain Analysis
Figure 79: Global: Mucosal Atomization Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Mucosal Atomization Devices Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Mucosal Atomization Devices Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Mucosal Atomization Devices Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Mucosal Atomization Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Mucosal Atomization Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Mucosal Atomization Devices Market: Competitive Structure
Table 7: Global: Mucosal Atomization Devices Market: Key Players

Product Code: SR112024A5370

The global mucosal atomization devices market size reached US$ 772.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,300.7 Million by 2032, exhibiting a growth rate (CAGR) of 5.92% during 2024-2032. The global market is growing rapidly, driven by technological advancements, the increasing demand for efficient drug delivery in medical emergencies, broadening applications in healthcare, and rapid expansion of the healthcare infrastructure in emerging economies, particularly in Asia-Pacific.

Mucosal Atomization Devices Market Analysis:

Market Growth and Size: The mucosal atomization devices market is experiencing significant growth, attributed to increasing demand across various medical fields. The market's expansion is further driven by the rising need for efficient drug delivery systems in both emergency and outpatient care settings.

Major Market Drivers: Key drivers include the enhanced efficiency of drug delivery through mucosal atomization, the growing prevalence of chronic diseases, and the need for rapid medication administration. Technological advancements and increasing awareness among healthcare professionals also play vital roles in driving market growth.

Technological Advancements: Continuous innovation in device design and functionality characterizes this market, with developments aimed at improving atomization quality, user-friendliness, and portability. Integration of digital health technologies for better dosage control and patient compliance is an emerging trend.

Industry Applications: Mucosal atomization devices find extensive applications in emergency medicine, pain management, ENT procedures, and chronic disease treatment. Their non-invasive nature and rapid drug absorption capabilities make them suitable for diverse medical scenarios.

Key Market Trends: The market is witnessing a trend towards more compact, efficient, and cost-effective devices. There's also an increasing focus on patient comfort and compliance, driving the development of user-friendly atomization devices.

Geographical Trends: North America dominates the market due to its advanced healthcare infrastructure and high prevalence of chronic diseases. Asia Pacific and Europe are also significant markets, showing rapid growth due to expanding healthcare facilities and rising healthcare spending.

Competitive Landscape: The market is characterized by the presence of key players engaging in strategic collaborations, R&D investments, and expansions into new markets. These companies are focused on enhancing their product portfolios and strengthening their global market positions.

Challenges and Opportunities: Challenges include stringent regulatory standards and the need for continuous technological advancements. However, these challenges present opportunities for innovation and development of new products that meet changing healthcare needs, especially in developing regions and emerging markets.

Mucosal Atomization Devices Market Trends:

Enhanced drug delivery efficiency

Mucosal atomization devices have gained prominence due to their ability to enhance the efficiency of drug delivery, particularly in emergency and outpatient settings. These devices facilitate rapid absorption of medication through the mucosal membrane, leading to quicker onset of action compared to traditional delivery methods. This is especially critical in cases requiring immediate medical intervention, such as pain management, seizure control, or reversal of opioid overdose. The fine mist produced by atomization ensures a larger surface area for drug absorption, improving bioavailability. This method also bypasses the gastrointestinal tract, eliminating concerns related to oral administration such as first-pass metabolism or gastrointestinal disturbances. Moreover, mucosal atomization is non-invasive, making it more acceptable to patients, especially children or those with difficulty swallowing pills. The growing emphasis on patient comfort and the need for rapid, effective medication administration in various clinical scenarios significantly drive the market for these devices.

Technological advancements and product innovation

The market is propelled by continuous technological advancements and product innovations. Modern devices offer improved atomization quality, creating a consistent particle size that enhances mucosal absorption. Innovations in design have led to more user-friendly, portable, and disposable atomizers, expanding their use in diverse medical settings. Developments in materials and manufacturing techniques have also reduced the cost of these devices, making them more accessible. There is a growing focus on developing devices with better control over dosage and spray pattern, catering to specific medical requirements. Additionally, advancements in digital health technology, such as integration with electronic medical records for dose tracking and patient compliance, are emerging trends. The ongoing research and development aimed at improving the efficacy, safety, and convenience of these devices significantly contribute to the expansion of this market.

Rising demand in various medical applications

The application scope of these devices extends across numerous medical fields, driving their market growth. In emergency medicine, these devices are crucial for rapid drug administration in critical care situations. In ENT (Ear, Nose, Throat) practices, they are used for efficient local anesthesia during procedures. Their use in pain management, especially for patients unable to take oral medication, is another key area of application. The growing prevalence of chronic diseases where regular medication is required, such as diabetes or hormonal disorders, presents additional opportunities for the use of mucosal atomization for drug delivery. Furthermore, the COVID-19 pandemic has highlighted the need for effective and safe drug delivery methods, with mucosal atomization being explored for vaccine administration. The versatility and growing applications of these devices in various medical specialties significantly contribute to the increasing demand and expansion of the mucosal atomization devices market.

Mucosal Atomization Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, technology and end user.

Breakup by Product Type:

Nasal Atomization Devices

Fiber-Optic Atomization Devices

Laryngo-Tracheal Atomization Devices

Bottle Atomizer Devices

Nasal atomization devices accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes nasal atomization devices, fiber-optic atomization devices, laryngo-tracheal atomization devices, and bottle atomizer devices. According to the report, nasal atomization devices represented the largest segment.

Nasal atomization devices are increasingly popular due to their non-invasive nature and ease of use, which improves patient compliance, especially in pediatric and geriatric populations. These devices are critical in delivering medications for conditions like seizures, pain management, and opioid overdoses, where rapid mucosal absorption is essential. The rising prevalence of chronic nasal and sinus conditions also contributes to the demand for these devices. Furthermore, ongoing research and development efforts aimed at improving nasal drug delivery efficacy are anticipated to continue driving the growth of this segment.

On the other hand, fiber-optic atomization devices are recognized for their precision in delivering medication to targeted areas, especially in ENT and pulmonary treatments. These devices utilize advanced technology to produce a fine mist, ensuring deep penetration and effective drug delivery to hard-to-reach mucosal surfaces. Their integration with fiber-optic technology allows for simultaneous visualization and treatment, enhancing the accuracy of procedures. The market for these devices is expanding with the increasing demand for minimally invasive medical treatments.

Moreover, laryngo-tracheal atomization devices are designed for targeted drug delivery to the larynx and trachea, primarily in anesthesia and respiratory therapies. Their specific design facilitates effective medication deposition in the lower respiratory tract, crucial for treatments like local anesthesia during intubations. These devices are gaining prominence in critical care and surgical settings due to their ability to provide quick and effective relief. The increasing number of surgeries requiring airway management is a significant factor contributing to the growth of this market segment.

Furthermore, bottle atomizer devices are simple, versatile, and widely used in various medical settings, from hospitals to home care. These devices are particularly useful for topical applications and throat treatments, offering easy handling and convenience. Their cost-effectiveness and broad applicability make them a popular choice in both developed and developing healthcare markets. The ongoing demand for easy-to-use and affordable medical devices supports the steady growth of this segment.

Breakup by Technology:

Gas Propelled

Electrical

Gas propelled holds the largest share in the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes gas propelled and electrical. According to the report, gas propelled accounted for the largest market share.

Gas propelled atomization devices are gaining traction due to their ability to deliver a fine mist of medication quickly and effectively, which is essential in time-sensitive medical situations. These devices are preferred in emergency medicine and critical care due to their reliability and ease of use, especially in scenarios where electrical power may not be readily available. Their portability makes them ideal for field use, including ambulance services and military applications. The consistent particle size produced by gas propulsion ensures efficient and uniform drug absorption, making them highly effective for various treatments. Additionally, these devices are often seen as cost-effective solutions, suitable for a wide range of healthcare settings.

On the other hand, electrical atomization devices are characterized by their precision and control in drug delivery, making them suitable for delicate medical procedures. These devices offer adjustable settings for particle size and spray intensity, allowing for customized medication delivery tailored to individual patient needs. They are commonly used in ENT and dental procedures where precise application is crucial. Their growing popularity is also attributed to advancements in battery technology, which enhances their portability and convenience in various healthcare environments.

Breakup by End User:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Hospitals are a major end-user segment for mucosal atomization devices due to their extensive use in emergency, ENT, and surgical procedures. The increasing number of hospital admissions involving cases requiring rapid drug administration boosts the demand for these devices. Hospitals typically favor advanced atomization devices that offer precision, reliability, and versatility to cater to various medical needs. The continuous investment in upgrading hospital equipment and the emphasis on improving patient care quality further contribute to the dominance of this segment in the market.

On the other hand, Clinics, especially those specializing in ENT, dental, and pediatric care, increasingly utilize mucosal atomization devices for various treatments. These settings often prefer devices that are easy to use, maintain, and provide effective localized treatment. The growing number of clinics globally, along with the rise in outpatient and minimally invasive procedures, is driving the demand for these devices. The convenience and efficacy of mucosal atomization in a clinical setting support the growth of this segment.

Furthermore, ambulatory surgical centers (ASCs) are adopting mucosal atomization devices to enhance their procedural efficiency and patient comfort. These centers benefit from the quick and effective drug delivery offered by these devices, particularly in procedures requiring local anesthesia or pain management. The increasing number of ASCs, coupled with the shift towards outpatient surgical procedures, contributes to the growing use of atomization devices. The trend towards minimally invasive surgeries, which require precise and targeted medication delivery, also supports the expansion of this market segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest mucosal atomization devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American market is primarily driven by the region's advanced healthcare infrastructure and heightened focus on emergency medical care. The presence of leading medical device manufacturers in this region, investing in R&D for innovative products, further propels market growth. Increasing awareness among healthcare professionals about the benefits of mucosal atomization in drug delivery, especially in emergency and outpatient settings, significantly contributes to the market expansion. The high prevalence of chronic diseases requiring effective medication management also plays a crucial role. Additionally, favorable government policies and healthcare reimbursement schemes in countries like the United States and Canada support the adoption of these advanced medical devices.

Asia Pacific's market is growing rapidly, largely due to the expanding healthcare infrastructure and increasing investments in medical technology in countries like China and India. The rising prevalence of chronic diseases and the growing elderly population in the region necessitate advanced drug delivery systems, boosting the demand for mucosal atomization devices. Additionally, the growing focus on improving emergency medical services and training healthcare professionals in advanced drug delivery techniques contributes to market growth. Moreover, the increasing affordability and availability of these devices in the region enhance their adoption in various medical settings.

Europe's market is influenced by the region's strong focus on healthcare quality and safety, driving the adoption of efficient drug delivery systems like mucosal atomization devices. The presence of well-established healthcare systems and high healthcare expenditure in European countries underpins the market growth. Additionally, the region's stringent regulatory standards for medical devices ensure the availability of high-quality and safe devices. The increasing prevalence of lifestyle-related diseases that require efficient medication management further stimulates the demand for these devices.

In Latin America, the market is gaining momentum due to the gradual improvement in healthcare infrastructure and increasing access to healthcare services. The growing awareness among healthcare providers about the efficacy and safety of mucosal atomization in drug delivery is a significant factor. Additionally, the rising incidence of chronic diseases in the region necessitates advanced drug delivery solutions. Furthermore, the increasing investments in the healthcare sector by governments and private entities are encouraging the adoption of innovative medical devices.

The market in the Middle East and Africa is developing, with increased healthcare spending and growing awareness of advanced medical technologies as key drivers. The region's focus on improving healthcare infrastructure, particularly in countries like Saudi Arabia and the United Arab Emirates, supports market growth. The rising prevalence of chronic diseases, coupled with the need for effective medication delivery systems, also contributes to the demand for mucosal atomization devices. Moreover, government initiatives to modernize healthcare services and promote medical tourism in some countries are fostering the adoption of advanced medical devices in the region.

Leading Key Players in the Mucosal Atomization Devices Industry:

The key players are actively engaged in various strategic initiatives to strengthen their market positions. These companies are heavily investing in research and development to innovate and improve the efficacy and safety of their devices. This includes the design of more user-friendly and cost-effective products to enhance patient compliance and expand market reach. Partnerships and collaborations with healthcare providers and institutions are being pursued to gain valuable insights and foster product adoption. Additionally, these players are focusing on expanding their global footprint through strategic mergers and acquisitions, and by entering new markets, especially in developing regions where healthcare infrastructure is rapidly improving.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Becton Dickinson and Company

DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)

Kurve Technology Inc.

Life-Assist Inc.

Medica Holdings LLC

MedTree (BTME Group Ltd.)

Teleflex Incorporated

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

December 7, 2023: Becton, Dickinson and Company today announced it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.

May 24, 2023: Drive DeVilbiss Healthcare launched a new, energy efficient 10 litre oxygen concentrator. For the first time ever, an oxygen device is being designed centering the needs of these unique whilst challenging environments. The oxygen concentrator is best placed to fulfill the need for oxygen therapy at the primary and secondary health levels in rural and semi-urban areas.

March 15, 2023: Today, Kurve Therapeutics (Kurve Tx) announced it has filed for new intellectual property on its nose-to-brain technology platform. Kurve's technology uses the neuronal pathway rather than the circulatory system, which means the drug is delivered to the extracellular space in the brain. This means there is the opportunity to move the drug once it reaches the brain.

Key Questions Answered in This Report

1. What was the size of the global mucosal atomization devices market in 2023?
2. What is the expected growth rate of the global mucosal atomization devices market during 2024-2032?
3. What are the key factors driving the global mucosal atomization devices market?
4. What has been the impact of COVID-19 on the global mucosal atomization devices market?
5. What is the breakup of the global mucosal atomization devices market based on the product type?
6. What is the breakup of the global mucosal atomization devices market based on the technology?
7. What is the breakup of the global mucosal atomization devices market based on the end user?
8. What are the key regions in the global mucosal atomization devices market?
9. Who are the key players/companies in the global mucosal atomization devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Mucosal Atomization Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Nasal Atomization Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Fiber-Optic Atomization Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Laryngo-Tracheal Atomization Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Bottle Atomizer Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Technology

7.1 Gas Propelled
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Electrical
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Becton Dickinson and Company
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Kurve Technology Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Life-Assist Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Medica Holdings LLC
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 MedTree (BTME Group Ltd.)
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Teleflex Incorporated
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis

粘膜噴霧デバイス市場レポート：製品タイプ、技術、エンドユーザー、地域別、2024-2032

Mucosal Atomization Devices Market Report by Product Type, Technology, End User, and Region 2024-2032

粘膜噴霧デバイス市場の分析：

粘膜噴霧デバイスの市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 粘膜噴霧デバイスの世界市場

第6章 市場内訳：製品タイプ別

第7章 市場内訳：技術別

第8章 市場内訳：エンドユーザー別

第9章 市場内訳：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

List of Figures

List of Tables

Mucosal Atomization Devices Market Analysis:

Mucosal Atomization Devices Market Trends:

Mucosal Atomization Devices Industry Segmentation:

Breakup by Product Type:

Breakup by Technology:

Breakup by End User:

Breakup by Region:

Leading Key Players in the Mucosal Atomization Devices Industry:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Latest News:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Mucosal Atomization Devices Market

6 Market Breakup by Product Type

7 Market Breakup by Technology

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章粘膜噴霧デバイスの世界市場

第6章市場内訳：製品タイプ別

第7章市場内訳：技術別

第8章市場内訳：エンドユーザー別

第9章市場内訳：地域別

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第13章価格分析

第14章競合情勢